The emerging therapy of the medication represents a major development in the management of type 2 diabetes. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide981332.bloggazza.com/40739553/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment